Sirtex Medical Limited is a global healthcare company specializing in the development and commercialization of innovative targeted therapies for cancer treatment. The company focuses on liver cancer, particularly through its proprietary radioembolization technology, which delivers localized radiation to tumors while minimizing damage to surrounding healthy tissue. Headquartered in North Sydney, Australia, Sirtex is dedicated to advancing cancer care through research and collaboration, aiming to improve patient outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#5 in North Sydney

#351 in Australia

#51,801 in the World

North Sydney, Australia

Sirtex Medical Limited

Forward Citations = 177

14 inventors:

Bruce Nathaniel Gray (7 out of 14 patents)

Stephen Keith Jones (3 out of 4 patents)

Andrew John Ruys (2 out of 2 patents)

4. Brendon Van Den Berg (1 out of 1 patent)

5. Gilman Wong (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sirtex Medical Limited. Retrieved from https://idiyas.com/company/sirtex-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]